Back

Cardiovascular risk assessment in multiple myeloma patients undergoing carfilzomib therapy: a new risk prediction model for cardiovascular adverse events

12 December 2020 (08:00 - 08:06)
Organised by:
Congress Presentation Part of: Live Abstract Presentations - Echo driven vigilence Imaging in Prevention and Rehabilitation EACVI Premium Access EACVI - Best of Imaging 2020

About the speaker

Photo
Doctor Anna Astarita

Hospital Citta Della Salute e della Scienza di Torino, Turin (Italy)

9 More presentations in this session

Presentation thumbnail
Prediction of long-term survival in haemoglobinopathies: insights from cardiac imaging and ferritin
Doctor V. Kamperidis (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
Prognostic role of echocardiography to predict cardiovascular involvement in systemic sclerosis
Doctor M. Mazzola (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Clinical and echocardiographic characteristics of patients with pathology proven left-sided non-valvular papillary fibroelastoma
Doctor E. El-Am (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Echocardiographic features and behavior of cardiac structural abnormalities in mucopolysaccharidosis
Doctor S. Saba (Wolverhampton, GB)
Abstract Slides Video
Presentation thumbnail
Accuracy of an integrated evaluation including clinical presentation, laboratory data and global longitudinal strain by echocardiography for diagnosing acute myocarditis.
Doctor A. Degiovanni (Novara, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Live Abstract Presentations - Echo driven vigilence

The Event

Event poster

EACVI - Best of Imaging 2020

12 December 2020 08:00 CET
You may be interested in
thumbnail
Webinar
Multimodality imaging in patients with suspected coronary artery disease: what to do and what to avoid
thumbnail
Congress Session
Use of imaging in electrophysiology
thumbnail
Congress Session
How to assess patients after transcatheter valve procedures

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources